UCB’s Vimpat gets NHS green light in Wales
The All Wales Medicines Strategy Group has approved NHS funding for the use of UCB’s Vimpat in children with epilepsy.
Read More
Tag: Vimpat
SMC approves NHS funding for UCB’s Vimpat in children
Children living in Scotland with epilepsy will get NHS-funded treatment with UCB’s Vimpat following a green light from cost regulators.
Read More
EU allows use of UCB’s anti-epileptic Vimpat in children
The European Commission has ruled that UCB’s anti-epileptic Vimpat can be used in children.
Read More
UCB bags key US patent win
UCB has secured an important win for the protection of its anti-epileptic Vimpat in the US this week after the Delaware District Court confirmed the validity of a key patent for the drug.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
